D. E. Shaw & Co., Inc. Global Blood Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $480,978 - $1.01 Million	-14,845 Reduced 5.05%	279,400 $19 Million
Q2 2022 Aug 15, 2022	BUY	$22.3 - $37.39 $6.26 Million - $10.5 Million	280,843 Added 2095.53%	294,245 $9.4 Million
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $344,651 - $477,653	-13,421 Reduced 50.04%	13,402 $464,000
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $444,041 - $717,956	-17,833 Reduced 39.93%	26,823 $785,000
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $1.14 Million - $1.67 Million	44,656 New	44,656 $1.14 Million
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $714,743 - $933,351	-18,355 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$37.65 - $63.77 $2.81 Million - $4.76 Million	-74,667 Reduced 80.27%	18,355 $795,000
Q3 2020 Nov 16, 2020	SELL	$52.76 - $74.49 $4.71 Million - $6.64 Million	-89,178 Reduced 48.95%	93,022 $5.13 Million
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $7.77 Million - $13.1 Million	-159,535 Reduced 46.68%	182,200 $11.5 Million
Q1 2020 May 15, 2020	BUY	$41.72 - $87.2 $9.96 Million - $20.8 Million	238,735 Added 231.78%	341,735 $17.5 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $9.87 Million - $17.7 Million	-215,947 Reduced 67.71%	103,000 $8.19 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $10.3 Million - $13.2 Million	228,206 Added 251.49%	318,947 $15.5 Million
Q2 2019 Aug 14, 2019	BUY	$52.6 - $63.29 $2.52 Million - $3.03 Million	47,918 Added 111.9%	90,741 $4.77 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $706,303 - $944,563	17,662 Added 70.2%	42,823 $2.27 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $158,046 - $233,863	5,011 Added 24.87%	25,161 $1.03 Million
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $765,700 - $1.03 Million	20,150 New	20,150 $766,000
Q2 2018 Aug 14, 2018	SELL	$38.7 - $50.15 $212,617 - $275,524	-5,494 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $506,998 - $843,717	-12,803 Reduced 69.97%	5,494 $265,000
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $543,420 - $836,172	18,297	18,297 $720,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account